|
| Cancer type | ITT subjects
( subjects) |
|
| Pancreatic | 45 (77.6%) |
| Cholangiocarcinoma | 3 (5.2%) |
| Ampullary | 2 (3.4%) |
| Colon | 2 (3.4%) |
| Lung | 2 (3.4%) |
| Other undefined malignancy | |
| Retroperitoneal mass, suspect sarcoma | |
| Malignant adenopathy of the porta hepatic portacaval, and pericardial regions | 4 (6.9%) |
| Peripancreatic malignant lymphadenopathy | |
| Lymphoma to porta hepatis | |
|